Chip Parkinson

Myriad Genetics has appointed Chip Parkinson as executive vice president for reimbursement strategy. He will report to President and CEO Mark Capone. Parkinson comes to Myriad from Cambia Health Solutions where he served as president of OmedRx and MedSavvy, and as chief pharmacy officer for Regence Blue Cross Blue Shield Health Plans. He has also served in general management and managed care leadership roles at Pfizer and Myriad.


Jason Flowerday

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.